General Information of the Compound
Compound ID
CP0419113
Compound Name
2-[3-(6-chloroimidazo[2,1-b][1,3]thiazol-5-yl)sulfonylpyrrolo[2,3-b]pyridin-1-yl]-N-methylethanamine
    Show/Hide
Structure
Formula
C15H14ClN5O2S2
Molecular Weight
395.897
Canonical SMILES
CNCCn1cc(c2cccnc12)S(=O)(=O)c1c(Cl)nc2sccn12
    Show/Hide
InChI
InChI=1S/C15H14ClN5O2S2/c1-17-5-6-20-9-11(10-3-2-4-18-13(10)20)25(22,23)14-12(16)19-15-21(14)7-8-24-15/h2-4,7-9,17H,5-6H2,1H3
    Show/Hide
InChIKey
CTYXKOVPFGUJOK-UHFFFAOYSA-N
Physicochemical Property
logP
2.4511
Rotatable Bonds
5
Heavy Atom Count
25
Polar Areas
81.29
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
8
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 45484340
ChEMBL ID
CHEMBL565746
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  2
1
IC50 = 5.4 nM
   TI
   LI
   LO
   TS
2
Ki = 0.9 nM
   TI
   LI
   LO
   TS